Table 5.
Colectomy at 12 mo of vedolizumab therapy
Colectomy, n | Australia | Oxford | P value |
19/210 | 13/93 | 0.25 | |
Colectomy, n | Anti-TNF naive | Anti-TNF exposed | P value |
9/182 | 23/121 | 0.0005 | |
Colectomy, n | Primary LOS | Secondary LOS | P value |
10/45 | 23/61 | 0.795 |
VDZ: Vedolizumab; TNF: Tumor necrosis factor; Primary LOR: Primary loss of response; Secondary LOR: Secondary loss of response.